Here, we showed that treatment with UroA or UAS03 in 5FUR colon cancer cells significantly induced FOXO3 expression and downregulated FOXM1, which in turn is potentially responsible for downregulation of drug transporters. The gene discussed is FOXM1; the disease is colonic neoplasm.